Surgical Endoscopy

, Volume 24, Issue 5, pp 1005–1010 | Cite as

Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes

  • F. Abbatini
  • M. Rizzello
  • G. Casella
  • G. Alessandri
  • D. Capoccia
  • F. Leonetti
  • N. Basso
Article

Abstract

Background

This study aimed to compare the efficacy of laparoscopic sleeve gastrectomy (SG) with that of laparoscopic gastric bypass (GBP) and laparoscopic adjustable gastric banding (AGB) for glucose homeostasis in morbidly obese subjects with type 2 diabetes mellitus (T2DM) at a 3-year follow-up assessment and to elucidate the role of weight loss in the T2DM resolution after SG.

Methods

For this study, 60 morbidly obese T2DM patients (44 females and 16 males) who underwent AGB (24 patients), GBP (16 patients), or SG (20 patients) between 1996 and 2008 were retrospectively analyzed. Age, sex, body mass index (BMI), estimated weight loss (EWL), fasting glycemia, HbA1c, euglycemic hyperinsulinemic clamp, discontinuation of diabetes treatment, and time until interruption of therapy were evaluated.

Results

In the study, 54 patients received oral hypoglycemic agents for at least 12 months before surgery, and 6 patients received insulin. The mean follow-up period was 36 months. The resolution rate was 60.8% for the AGB patients, 81.2% for the GBP patients, and 80.9% for the SG patients. The postoperative time until interruption of therapy was 12.6 months for the AGB patients, 3.2 months for the GBP patients, and 3.3 months for the SG patients. The hyperinsulinemic euglycemic clamp test was performed 12 months after surgery for the cured patients. Insulin resistance was restored to normal values in all the patients. The greatest improvement from preoperative values occurred in the SG group. For the not-cured GBP and SG patients, an improvement of 120 mg/dl in fasting plasma glucose was observed 3 months after the surgery, suggesting an enhancement in insulin sensitivity, which determines better medical control. The resolution rate remained constant at the 36-month follow-up evaluation in both the GBP and SG groups.

Conclusions

All three bariatric procedures are effective in treating diabetes, with a 3-year follow-up evaluation showing an effect that lasts. The AGB procedure was the least effective. The antidiabetic effect was similarly precocious after GBP and SG compared with AGB. This difference may indicate that a hormonal mechanism may be involved, independent of weight loss.

Keywords

Bariatric surgery Diabetes Gastric banding Gastric bypass Morbid obesity Sleeve gastrectomy 

References

  1. 1.
    Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737CrossRefPubMedGoogle Scholar
  2. 2.
    Elder KA, Wolfe BM (2007) Bariatric surgery: a review of procedures and outcomes. Gastroenterology 132:2253–2271CrossRefPubMedGoogle Scholar
  3. 3.
    Deitel M, Crosby RD, Gagner M (2008) The first international consensus summit for Sleeve Gastrectomy (SG), New York City, October 25–27, 2007. Obes Surg 18:487–496CrossRefPubMedGoogle Scholar
  4. 4.
    Regan JP, Inabnet WB, Gagner M, Pomp A (2003) Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 13:861–864CrossRefPubMedGoogle Scholar
  5. 5.
    Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK (2008) Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double-blind study. Ann Surg 247:401–407CrossRefPubMedGoogle Scholar
  6. 6.
    Lee CM, Cirangle PT, Jossart GH (2007) Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc 21:1810–1816 Epub. 14 March 2007CrossRefPubMedGoogle Scholar
  7. 7.
    Himpens J, Dapri G, Cadière GB (2006) A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 16:1450–1456CrossRefPubMedGoogle Scholar
  8. 8.
    Cummings DE, Overduin J, Foster-Schubert KE (2004) Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 89:2608–2615CrossRefPubMedGoogle Scholar
  9. 9.
    Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D (2003) Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467–484; discussion 84–85PubMedGoogle Scholar
  10. 10.
    Sugerman HJ, Wolfe LG, Sica DA, Clore JN (2003) Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 237:751–756CrossRefPubMedGoogle Scholar
  11. 11.
    Sjöström CD, Lissner L, Wedel H, Sjöström L (1999) Reduction in incidence of diabetes, hypertension, and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 7:477–484PubMedGoogle Scholar
  12. 12.
    Pories WJ, Mac Donald KG, Jr Morgan EJ, Sinha MK, Dohm GL, Swanson MS et al (1992) Surgical treatment of obesity and its effect on diabetes: 10-year follow-up. Am J Clin Nutr 55(2 Suppl):582S–585SPubMedGoogle Scholar
  13. 13.
    Hickey MS, Pories WJ, MacDonald KG Jr, Cory KA, Dohm GL, Swanson MS, Israel RG, Barakat HA, Considine RV, Caro JF, Houmard JA (1998) A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg 227:637–643CrossRefPubMedGoogle Scholar
  14. 14.
    Mingrone G (2008) Role of the incretin system in the remission of type 2 diabetes following bariatric surgery. Nutr Metab Cardiovasc Dis 18:574–579CrossRefPubMedGoogle Scholar
  15. 15.
    Vidal J, Ibarzabal A, Romero F, Delgado S, Momblán D, Flores L, Lacy A (2008) Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 18:1077–1082CrossRefPubMedGoogle Scholar
  16. 16.
    DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMedGoogle Scholar
  17. 17.
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMedGoogle Scholar
  18. 18.
    Belachew M, Jacqet P, Lardinois F, Karler C (1993) Vertical banded gastroplasty vs adjustable silicone gastric banding in the treatment of morbid obesity: a preliminary report. Obes Surg 3:275–278CrossRefPubMedGoogle Scholar
  19. 19.
    Inabnet WB, Quinn T, Gagner M, Urban M, Pomp A (2005) Laparoscopic Roux-en-Y gastric bypass in patients with BMI <50: a prospective randomized trial comparing short and long limb lengths. Obes Surg 15(1):51–57Google Scholar
  20. 20.
    Shulman GI (1999) Cellular mechanisms of insulin resistance in humans. Am J Cardiol 84:3J–10JCrossRefPubMedGoogle Scholar
  21. 21.
    Kahn BB, Flier JS (2000) Obesity and insulin resistance. J Clin Invest 106:473–481CrossRefPubMedGoogle Scholar
  22. 22.
    Friedman JM (2000) Obesity in the new millennium. Nature 404:632–634PubMedGoogle Scholar
  23. 23.
    Fischer S, Hanefeld M, Haffner SM, Fusch C, Schwanebeck U, Köhler C, Fücker K, Julius U (2002) Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass. Acta Diabetol 39:105–110CrossRefPubMedGoogle Scholar
  24. 24.
    Franssila-Kallunki A, Rissanen A, Ekstrand A, Ollus A, Groop L (1992) Weight loss by very-low-calorie diets: effects on substrate oxidation, energy expenditure, and insulin sensitivity in obese subjects. Am J Clin Nutr 56(1 Suppl):247S–248SPubMedGoogle Scholar
  25. 25.
    Cummings S, Apovian CM, Khaodhiar L (2008) Obesity surgery: evidence for diabetes prevention/management. J Am Diet Assoc 108(4 Suppl 1):S40–S44CrossRefPubMedGoogle Scholar
  26. 26.
    Yada T, Dezaki K, Sone H, Koizumi M, Damdindorj B, Nakata M, Kakei M (2008) Ghrelin regulates insulin release and glycemia: physiological role and therapeutic potential. Curr Diabetes Rev 4:18–23CrossRefPubMedGoogle Scholar
  27. 27.
    Micic D, Duntas L, Cvijovic G, Kendereski A, Sumarac-Dumanovic M, Jehle P, Zoric S, Pejkovic D, Lague M, Dieguez C, Casanueva F (2007) Ghrelin and the enteroinsular axis in healthy men. Hormones (Athens) 6:321–326Google Scholar
  28. 28.
    Campbell CD, Lyon HN, Nemesh J, Drake JA, Tuomi T, Gaudet D, Zhu X, Cooper RS, Ardlie KG, Groop LC, Hirschhorn JN (2007) Association studies of BMI and type 2 diabetes in the neuropeptide Y pathway: a possible role for NPY2R as a candidate gene for type 2 diabetes in men. Diabetes 56:1460–1467CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • F. Abbatini
    • 1
  • M. Rizzello
    • 1
  • G. Casella
    • 1
  • G. Alessandri
    • 1
  • D. Capoccia
    • 2
  • F. Leonetti
    • 2
  • N. Basso
    • 1
  1. 1.Department of Surgical-Medical Digestive Diseases, Policlinico “Umberto I”University “La Sapienza”RomeItaly
  2. 2.Department of Clinical Sciences, Policlinico “Umberto I”University “La Sapienza”RomeItaly

Personalised recommendations